About Benjamin Cravatt, Ph.D.
Form D filings for Boundless Bio from 2020 to 2023 list Benjamin Cravatt, Ph.D. as director.
Benjamin Cravatt, Ph.D. first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Cravatt, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Benjamin Cravatt, Ph.D. works with at each company, as listed on that company's latest Form D.
Boundless Bio, Inc. · Form D, Aug 15, 2023
ZH
Zachary Hornby
CEO, President, and Director
FD
Fabio Pucci, Ph.D.
Director
JD
Jakob Loven, Ph.D.
Director
JL
Jennifer Lew
Director
CD
Christine Brennan, Ph.D.
Director
JD
Jonathan Lim, M.D.
Director
KB
Kristina Burow
Director